Top Markets
Coin of the day
OnKure Therapeutics, Inc. OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.

OKUR
Rank in Stocks #19593
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a... OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
Share Price
$3.86
Last synced: 2026-08-25
Market Cap
$156.32M
Change (1 day)
-0.77%
Change (1 year)
40.36%
Country
US
Trade OnKure Therapeutics, Inc. (OKUR)

Category

Operating Margin for OnKure Therapeutics, Inc. (OKUR)
Operating Margin as of 2026 TTM: 0.00%
According to OnKure Therapeutics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for OnKure Therapeutics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
-149.01% -
US
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.